To overall evaluate the clinical therapeutic effects and safety of Longqing Tablets in the treatment of different types of chronic prostatitis based on Meta-analysis method，and to provide evidence-based medical evidence for rational drug treatment in clinic.Methods:According to the retrieval strategy，the Chinese and English databases，the Cochrane Library，Web of science，PubMed，Embase，ProQuest，China Biomedical Abstracts Database，China HowNet，Wanfang and Weipu were retrieved by computer with the subject words and free words method.The time was set from the establishment of the database to August 2019，and the manual search of mainstream Chinese and English magazines in recent years was combined.The final literature was obtained through software rechecking，title selection，abstract selection and paper content selection.Results:A total of 12 randomized controlled literature were finally included，with 2 621 patients.Meta-analysis showed that the total effective rate of the 2 groups of patients was as follows：［RR=1.42，95% CI(1.20，1.68)，P<0.000 1］; NIH-CPSI scores of the 2 groups：［MD=-4.81，95% CI(-7.00,-2.61)，P<0.000 1］; White blood cell count in prostatic massage fluid(EPS)of the 2 groups：［MD=-1.31，95% CI(-2.05,-0.58)，P＝0.0004］; Adverse reactions incidence rate of the 2 groups：［RR=0.81，95% CI(0.31，2.08)，P＝0.65］.Conclusion:The Longqing Tablets has significant effects in the treatment of chronic prostatitis.Compared with the control group，the NIH-CPSI score and EPS white blood cell count in the treatment group decreased significantly，and there were no serious adverse reactions.